Valneva extends interest-only period of debt facility by 18 months

By Marisa Wong

Los Angeles, March 18 – Valneva SE announced an agreement with funds managed by Deerfield Management Co. and OrbiMed to extend the interest-only period of its existing loan by 18 months, according to a press release.

Reimbursements of the first $100 million tranche will now start in January 2026 instead of July 2024.

Maturity of this first tranche will remain in the first quarter of 2027.

The terms of the second $100 million tranche remain unchanged.

The specialty vaccine company is based in Saint-Herblain, France.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.